Continuous home ambulatory intravenous inotropic drug therapy in severe heart failure: safety and cost efficacy (Q73940048)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9398101%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

Continuous home ambulatory intravenous inotropic drug therapy in severe heart failure: safety and cost efficacy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9398101%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

A P Sindone

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9398101%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

A M Keogh

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9398101%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

P S Macdonald

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9398101%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

C J McCosker

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9398101%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

A F Kaan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9398101%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

language of work or name

English

0 references

publication date

1 November 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9398101%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

published in

American Heart Journal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9398101%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

134

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9398101%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

5 Pt 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9398101%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

889-900

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9398101%20AND%20SRC:MED&resulttype=core&format=json

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2980012-9

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2980012-9

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2980012-9

Oxygen uptake/supply dependency. Effects of short-term dobutamine infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2980012-9

Coronary vasodilating action of dobutamine in patients with idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2980012-9

Oxygen transport measurements to evaluate tissue perfusion and titrate therapy: dobutamine and dopamine effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2980012-9

Combined dose ratios of dopamine and dobutamine and right ventricular performance after cardiac surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2980012-9

The hemodynamic and metabolic advantages gained by a three-day infusion of dobutamine in patients with congestive cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2980012-9

Drugs five years later. Dobutamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2980012-9

The Australian and New Zealand Cardiothoracic Organ Transplant Registry: first report 1984-1992

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2980012-9

Outpatient dobutamine and dopamine infusions in the management of chronic heart failure: clinical experience in 21 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2980012-9

Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2980012-9

Intermittent ambulatory dobutamine infusions for patients awaiting cardiac transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2980012-9

Tolerance to dobutamine after a 72 hour continuous infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2980012-9

Hemodynamic effect of dobutamine in patients with severe heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2980012-9

The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2980012-9

Intermittent, continuous outpatient dobutamine infusion in the management of congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2980012-9

Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2980012-9

Survival of Patients with Nonsustained Ventricular Tachycardia and Impaired Left Ventricular Function Treated with Low-Dose Amiodarone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2980012-9

Prospective, double-blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2980012-9

Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2980012-9

Side effects from amiodarone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2980012-9

Pharmacology and pharmacokinetics of amiodarone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2980012-9

The stability of four catecholamines in 5% glucose infusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2980012-9

Intravenous infusions of nitroprusside, dobutamine, and nitroglycerin are compatible

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2980012-9

Long-term benefit of dobutamine in patients with congestive cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2980012-9

Sustained improvement of cardiac function in patients with congestive heart failure after short-term infusion of dobutamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2980012-9

Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2980012-9

Prevention of bedrest-induced physical deconditioning by daily dobutamine infusions. Implications for drug-induced physical conditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2980012-9

Outpatient dobutamine infusion using a totally implantable infusion pump for refractory congestive heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2980012-9

Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2980012-9

Drug-induced conditioning in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2980012-9

10.1016/S0002-8703(97)80012-9

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9398101%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference